Dr. Grinstead discusses one of the most challenging types of chronic pain—neuropathic pain.
Raili Kauppinen (University Hospital of Helsinki, Finland) shares key findings and insights into the ENVISION study, which evaluated the efficacy and safety of givosiran, a subcutaneously administered RNA interference therapeutic targeting aminolevulinic acid synthase 1, in patients with acute hepatic porphyrias (ClinicalTrials.gov Identifier: NCT03338816). Questions 1. Could you give us a brief overview of acute […]
Nadine Attal (University Versailles Saint Quentin, Versailles, France) shared with us her expert opinion on the controversial topic of therapeutic cannabis for neuropathic pain. Questions 1. What advantages does cannabis offer compared to current pharmacological treatments for neuropathic pain? (0:05) 2. What can we conclude about the clinical evidence to date? (0:41) 3. What have […]
Ms. Joanna Chow of Toronto, Canada shared her story of becoming a spinal cord stimulation patient for chronic pain, speaking at an educational event by the Canadian Neuromodulation Society (CNS) and the International Neuromodulation Society (INS). In Part II she describes receiving the therapy that she continues to use. (Due to a camera malfunction, the […]
Get the latest clinical insights from touchNEUROLOGY
